Patents by Inventor Peter C. Simpson

Peter C. Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10737025
    Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: August 11, 2020
    Assignee: DexCom, Inc.
    Inventors: Anna Leigh Davis, Scott M. Belliveau, Naresh C. Bhavaraju, Leif N. Bowman, Rita M. Castillo, Alexandra Elena Constantin, Rian Draeger, Laura J. Dunn, Gary Brian Gable, Arturo Garcia, Thomas Hall, Hari Hampapuram, Christopher Robert Hannemann, Anna Claire Harley-Trochimczyk, Nathaniel David Heintzman, Andrea J. Jackson, Lauren Hruby Jepson, Apurv Ullas Kamath, Katherine Yerre Koehler, Aditya Sagar Mandapaka, Samuel Jere Marsh, Gary A. Morris, Subrai Girish Pai, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Ashley Anne Rindfleisch, Sofie Wells Schunk, Peter C. Simpson, Daniel Smith, Stephen J. Vanslyke, Matthew T. Vogel, Tomas C. Walker, Benjamin Elrod West, Atiim Joseph Wiley
  • Publication number: 20200245917
    Abstract: A transcutaneous sensor device configured for continuously measuring analyte concentrations in a host is provided. In some embodiments, the transcutaneous sensor device 100 comprises an in vivo portion 160 configured for insertion under the skin 180 of the host and an ex vivo portion 170 configured to remain above the surface of the skin 180 of the host after sensor insertion of the in vivo portion. The in vivo portion may comprise a tissue piercing element 110 configured for piercing the skin 180 of the host and a sensor body 120 comprising a material or support member 130 that provides sufficient column strength to allow the sensor body to be pushable in a host tissue without substantial buckling. The ex vivo portion 170 may be configured to comprise (or operably connect to) a sensor electronics unit and may comprise a mounting unit 150. Also described here are various configurations of the sensor body and the tissue piercing element that may be used to protect the membrane of the sensor body.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Inventors: Peter C. Simpson, Robert J. Boock, Sebastian Bohm, James H. Brauker, Paul V. Neale
  • Publication number: 20200245914
    Abstract: Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.
    Type: Application
    Filed: April 17, 2020
    Publication date: August 6, 2020
    Inventors: Naresh C. Bhavaraju, Michael A. Bloom, Leif N. Bowman, Alexandra Lynn Carlton, Katherine Yerre Koehler, Hari Hampapuram, Lauren Hruby Jepson, Jonathan Hughes, Apurv Ullas Kamath, Anna Leigh Davis, Peter C. Simpson, Stephen J. Vanslyke
  • Patent number: 10729364
    Abstract: Systems and methods are disclosed which provide for a “factory-calibrated” sensor. In doing so, the systems and methods include predictive prospective modeling of sensor behavior, and also include predictive modeling of physiology. With these two correction factors, a consistent determination of sensitivity can be achieved, thus achieving factory calibration.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: August 4, 2020
    Assignee: DexCom, Inc.
    Inventors: Rui Ma, Naresh C. Bhavaraju, Thomas Stuart Hamilton, Jonathan Hughes, Jeff Jackson, David I-Chun Lee, Peter C. Simpson, Stephen J. Vanslyke
  • Publication number: 20200245385
    Abstract: Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are disclosed. In an embodiment, a method for transmitting data between a first communication device associated with an analyte sensor and a second communication device configured to provide user access to sensor-related information comprises: activating a transceiver of a first communication device associated with an analyte sensor at a first time; and establishing a two-way communication channel with the second communication device; wherein the activating comprises waking the transceiver from a low power sleep mode using a forced wakeup from the second communication device.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Thomas Miller, Mark Dervaes, Phong Lieu, Peter C. Simpson, Shawn Larvenz, Jacob S. Leach, Sebastian Bohm
  • Patent number: 10722162
    Abstract: Systems and methods for processing sensor data and self-calibration are provided. In some embodiments, systems and methods are provided which are capable of calibrating a continuous analyte sensor based on an initial sensitivity, and then continuously performing self-calibration without using, or with reduced use of, reference measurements. In certain embodiments, a sensitivity of the analyte sensor is determined by applying an estimative algorithm that is a function of certain parameters. Also described herein are systems and methods for determining a property of an analyte sensor using a stimulus signal. The sensor property can be used to compensate sensor data for sensitivity drift, or determine another property associated with the sensor, such as temperature, sensor membrane damage, moisture ingress in sensor electronics, and scaling factors.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: July 28, 2020
    Assignee: DexCom, Inc.
    Inventors: Sebastian Böhm, Daiting Rong, Peter C. Simpson
  • Patent number: 10722152
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: July 28, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Patent number: 10722161
    Abstract: Disclosed herein are devices, systems, and methods for a continuous analyte sensor, such as a continuous glucose sensor. In certain embodiments disclosed herein, various in vivo properties of the sensor's surroundings can be measured. In some embodiments, the measured properties can be used to identify a physiological response or condition in the body. This information can then be used by a patient, doctor, or system to respond appropriately to the identified condition.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 28, 2020
    Assignee: DexCom, Inc.
    Inventors: Naresh C. Bhavaraju, Sebastian Bohm, Robert J. Boock, Daiting Rong, Peter C. Simpson
  • Patent number: 10709362
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: July 14, 2020
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Patent number: 10709363
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: July 14, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Publication number: 20200214565
    Abstract: Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are disclosed. In an embodiment, a method for transmitting data between a first communication device associated with an analyte sensor and a second communication device configured to provide user access to sensor-related information comprises: activating a transceiver of a first communication device associated with an analyte sensor at a first time; and establishing a two-way communication channel with the second communication device; wherein the activating comprises waking the transceiver from a low power sleep mode using a forced wakeup from the second communication device.
    Type: Application
    Filed: March 18, 2020
    Publication date: July 9, 2020
    Inventors: Thomas Miller, Mark Dervaes, Phong Lieu, Peter C. Simpson, Shawn Larvenz, Jacob S. Leach, Sebastian Bohm
  • Patent number: 10702193
    Abstract: Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: July 7, 2020
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker
  • Publication number: 20200205705
    Abstract: Various examples described herein are directed to systems, apparatuses, and methods for mitigating break-in in an analyte sensor. An example analyte sensor system comprises an analyte sensor applicator comprising a needle; an analyte sensor comprising at least a working electrode and a reference electrode, the analyte sensor positioned at least partially within a lumen of the needle; and a hydrating agent positioned within the lumen of the needle to at least partially hydrate the needle.
    Type: Application
    Filed: December 27, 2019
    Publication date: July 2, 2020
    Inventors: Ted Tang Lee, Anna Leigh Davis, Peter C. Simpson, Liang Wang, Shanger Wang, Jiong Zou, Stephen J. Vanslyke, Rui Ma, Wenjie Lan
  • Patent number: 10687740
    Abstract: The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: June 23, 2020
    Assignee: DexCom, Inc.
    Inventors: Sebastian Bohm, Mark Dervaes, Eric Johnson, Apurv Ullas Kamath, Shawn Larvenz, Jacob S. Leach, Phong Lieu, Aarthi Mahalingam, Tom Miller, Paul V. Neale, Jack Pryor, Thomas A. Peyser, Daiting Rong, Kenneth San Vicente, Mohammad Ali Shariati, Peter C. Simpson, Matthew Wightlin
  • Publication number: 20200187776
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Application
    Filed: February 20, 2020
    Publication date: June 18, 2020
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Publication number: 20200187834
    Abstract: The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
    Type: Application
    Filed: February 25, 2020
    Publication date: June 18, 2020
    Inventors: James R. Petisce, Mark A. Tapsak, Peter C. Simpson, Victoria Carr-Brendel, James H. Brauker
  • Patent number: 10682084
    Abstract: Systems and methods for processing sensor data and self-calibration are provided. In some embodiments, systems and methods are provided which are capable of calibrating a continuous analyte sensor based on an initial sensitivity, and then continuously performing self-calibration without using, or with reduced use of, reference measurements. In certain embodiments, a sensitivity of the analyte sensor is determined by applying an estimative algorithm that is a function of certain parameters. Also described herein are systems and methods for determining a property of an analyte sensor using a stimulus signal. The sensor property can be used to compensate sensor data for sensitivity drift, or determine another property associated with the sensor, such as temperature, sensor membrane damage, moisture ingress in sensor electronics, and scaling factors.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: June 16, 2020
    Assignee: DexCom, Inc.
    Inventors: Sebastian Böhm, Daiting Rong, Peter C. Simpson
  • Publication number: 20200170671
    Abstract: The present embodiments relate generally to systems and methods for measuring an analyte in a host. More particularly, the present embodiments provide sensor applicators and methods of use with activation that implant the sensor, withdraw the insertion needle, engage the transmitter with the housing, and disengage the applicator from the housing. Systems and methods according to present principles allow for such steps to occur without significant loss of spring force, and without deleterious effects such as seal slingshotting.
    Type: Application
    Filed: February 6, 2020
    Publication date: June 4, 2020
    Inventors: Ryan Everett Schoonmaker, Jennifer Blackwell, Christopher M. Davis, David DeRenzy, Eric Gobrecht, Jason Halac, Jonathan Hughes, Kathleen Suzanne Hurst, Randall Scott Koplin, Phong Lieu, Kyle Neuser, Todd Andrew Newhouse, Jack Pryor, Peter C. Simpson, Maria Noel Brown Wells, Justen Deering England, Stefanie Lynn Mah, Leonard Darius Barbod, Jillian K. Allen, Michael J. Estes, Philip Thomas Pupa, Timothy Joseph Goldsmith, Kyle Tinnell Keller
  • Publication number: 20200170508
    Abstract: Systems and methods are provided to calibrate an analyte concentration sensor within a biological system, generally using only a signal from the analyte concentration sensor. For example, at a steady state, the analyte concentration value within the biological system is known, and the same may provide a source for calibration. Similar techniques may be employed with slow-moving averages. Variations are disclosed.
    Type: Application
    Filed: February 5, 2020
    Publication date: June 4, 2020
    Inventors: Arturo Garcia, Peter C. Simpson, Apurv Ullas Kamath, Naresh C. Bhavaraju, Stephen J. Vanslyke
  • Patent number: 10667730
    Abstract: Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: June 2, 2020
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker